News
19h
Zacks Investment Research on MSNHere is What to Know Beyond Why CRISPR Therapeutics AG (CRSP) is a Trending Stock
CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...
15h
TipRanks on MSNCrispr Therapeutics’ CTX112 Study: A New Frontier in Autoimmune Disease Treatment
Crispr Therapeutics (($CRSP)) announced an update on their ongoing clinical study. Study Overview: The clinical study titled A Phase 1 Dose ...
23h
News Medical on MSNCRISPR Uncovers Hidden Microproteins That Could Help Treat Obesity
Salk Institute scientists are looking for a new treatment strategy in microproteins, an understudied class of molecules found ...
By using a protein called Cas9 to find and remove a damaged portion of a genetic sequence and then replace it using a ...
Researchers developed a method to dissect immune-regulatory programs via integrative time-series analysis and high-content CRISPR screening.
The FDA's approval of the first CRISPR-Cas9–based gene therapy marked a major milestone in biomedicine, validating genome ...
A large language model can design and troubleshoot CRISPR protocols from scratch, allowing first-time researchers to achieve ...
The candy giant is using Pairwise’s plant-breeding technology to improve cocoa production as climate challenges and disease ...
CRISPR gene editing shows potential for treating genetic diseases. Explore how it may impact Down syndrome treatment and ...
The multiagent AI system, dubbed “CRISPR-GPT,” is designed to interact and reason with human users as they execute ...
A team from UC San Diego, John Hopkins and UC Berkeley Universities found a way to edit a single gene in a mosquito that ...
CRISPR reached a big milestone this year by treating a disease inside the body—here's what's next for the technology. By Rebecca Sohn Updated Jul 28, 2021 5:01 PM EDT Get the Popular Science ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results